APA (7th ed.) Citation

Okubo, M., Narita, M., Murayama, N., Akimoto, Y., Goto, A., & Yamazaki, H. (2016). Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3. Human psychopharmacology, 31(2), 83-92. https://doi.org/10.1002/hup.2515

Chicago Style (17th ed.) Citation

Okubo, Maho, Momoko Narita, Norie Murayama, Youichi Akimoto, Akiko Goto, and Hiroshi Yamazaki. "Individual Differences in in Vitro and in Vivo Metabolic Clearances of the Antipsychotic Drug Olanzapine from Non-smoking and Smoking Japanese Subjects Genotyped for Cytochrome P4502D6 and Flavincontaining Monooxygenase 3." Human Psychopharmacology 31, no. 2 (2016): 83-92. https://doi.org/10.1002/hup.2515.

MLA (9th ed.) Citation

Okubo, Maho, et al. "Individual Differences in in Vitro and in Vivo Metabolic Clearances of the Antipsychotic Drug Olanzapine from Non-smoking and Smoking Japanese Subjects Genotyped for Cytochrome P4502D6 and Flavincontaining Monooxygenase 3." Human Psychopharmacology, vol. 31, no. 2, 2016, pp. 83-92, https://doi.org/10.1002/hup.2515.